Search
for

    Learn

    5 / 12 results

      learn Finasteride

      Frontline, gold standard treatment for combatting androgenic alopecia

      learn Vitamin D

      vitamin you should probably be taking for general health might also help your hair a little

      learn Follistatin

      glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin

      learn Neem Oil

      natural substance from Neem tree with medicinal and pesticidal properties

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community does lowering your prolactin levels regrow hair?

      in Research/Science  9 upvotes 3 years ago
      The potential of lowering prolactin levels to regrow hair, with a reference to Bayer's drug HMI 115 which has been indicated as having this effect. Treatments mentioned include Minoxidil and Finasteride, as well as RU58841.

      community Does lowering serum prolactin lower prolactin in the scalp?

      in Research/Science  13 upvotes 2 years ago
      The conversation discusses whether not masturbating (semen retention) affects hair loss, with opinions varying but generally dismissing the idea. Some participants mention using hair loss treatments like Minoxidil, Finasteride, and RU58841, but the effectiveness and relation to prolactin levels in the scalp are debated.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  110 upvotes 2 years ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.